Top

Published in:

01-02-2017 | Letter to the Editor

Comparing VA to Non-VA Care

Authors: Claire E. O’Hanlon, M.P.P., Carrie Farmer, Ph.D., Courtney Gidengil, M.D., M.P.H.

Published in: Journal of General Internal Medicine | Issue 2/2017

Excerpt

To the Editor: We thank Dr. Weeks for his thoughtful comments on our manuscript. Based on our review of the evidence in the published literature, we concluded that the VA often, but not always, performs better than or similarly to other systems of care with regard to safety and effectiveness. We did not conclude, or intend to imply, that we now know definitively that VA care overall is better than non-VA care, especially considering how few studies have been published on VA care with regard to the quality dimensions of timeliness, patient-centeredness, efficiency, and equity. …

Borzecki AM, Christiansen CL, Loveland S, Chew P, Rosen AK. Trends in the inpatient quality indicators: the Veterans Health Administration experience. Med Care. 2010;48(8):694–702.CrossRefPubMed

Krein SL, Hofer TP, Kowalski CP, Olmsted RN, Kauffman CA, Forman JH, Banaszak-Holl J, Saint S. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clin Proc. 2007;82(6):672–678.CrossRefPubMed

Vaughan-Sarrazin MS, Wakefield B, Rosenthal GE. Mortality of Department of Veterans Affairs patients undergoing coronary revascularization in private sector hospitals. Health Serv Res. 2007;42(5):1802–1821.CrossRefPubMedPubMedCentral

Title: Comparing VA to Non-VA Care
Authors: Claire E. O’Hanlon, M.P.P.
Carrie Farmer, Ph.D.
Courtney Gidengil, M.D., M.P.H.
Publication date: 01-02-2017
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 2/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-016-3892-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparing VA to Non-VA Care

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2017

Rates of Recovery to Pre-Fracture Function in Older Persons with Hip Fracture: an Observational Study

The Electrocardiogram Following Dynamic Cardiomyoplasty

Metoprolol-induced Total Body Erythroderma

Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis